Unit 1 total normalized DOT was significantly lower than expected in waves 2 and 3; piperacillin/tazobactam level was the lowest consumption in wave 1 and showed the lowest mean across the whole 12-month period, thus preventing a significant trend from emerging.
← all excerpts
Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times.
1
—
—